Analysis of the human kidney transcriptome and plasma proteome identifies markers of proximal tubule maladaptation to injury.
Yumeng WenEmily Y SuLeyuan XuSteven MenezDennis G MoledinaWassim ObeidSusan T CrowleySherry G MansourPrasad DevarajanLloyd G CantleyPatrick CahanChirag R Parikhnull nullnull nullPublished in: Science translational medicine (2023)
Acute kidney injury (AKI) is a major risk factor for long-term adverse outcomes, including chronic kidney disease. In mouse models of AKI, maladaptive repair of the injured proximal tubule (PT) prevents complete tissue recovery. However, evidence for PT maladaptation and its etiological relationship with complications of AKI is lacking in humans. We performed single-nucleus RNA sequencing of 120,985 nuclei in kidneys from 17 participants with AKI and seven healthy controls from the Kidney Precision Medicine Project. Maladaptive PT cells, which exhibited transcriptomic features of dedifferentiation and enrichment in pro-inflammatory and profibrotic pathways, were present in participants with AKI of diverse etiologies. To develop plasma markers of PT maladaptation, we analyzed the plasma proteome in two independent cohorts of patients undergoing cardiac surgery and a cohort of marathon runners, linked it to the transcriptomic signatures associated with maladaptive PT, and identified nine proteins whose genes were specifically up- or down-regulated by maladaptive PT. After cardiac surgery, both cohorts of patients had increased transforming growth factor-β2 (TGFB2), collagen type XXIII-α1 (COL23A1), and X-linked neuroligin 4 (NLGN4X) and had decreased plasminogen (PLG), ectonucleotide pyrophosphatase/phosphodiesterase 6 (ENPP6), and protein C (PROC). Similar changes were observed in marathon runners with exercise-associated kidney injury. Postoperative changes in these markers were associated with AKI progression in adults after cardiac surgery and post-AKI kidney atrophy in mouse models of ischemia-reperfusion injury and toxic injury. Our results demonstrate the feasibility of a multiomics approach to discovering noninvasive markers and associating PT maladaptation with adverse clinical outcomes.
Keyphrases
- acute kidney injury
- cardiac surgery
- chronic kidney disease
- end stage renal disease
- patients undergoing
- single cell
- transforming growth factor
- mouse model
- genome wide
- ischemia reperfusion injury
- rna seq
- endothelial cells
- induced apoptosis
- peritoneal dialysis
- prognostic factors
- ejection fraction
- risk factors
- oxidative stress
- gene expression
- body composition
- small molecule
- patient reported outcomes
- transcription factor
- signaling pathway
- electronic health record
- binding protein